Form 8-K - Current report:
SEC Accession No. 0001558370-25-008512
Filing Date
2025-06-10
Accepted
2025-06-10 16:35:46
Documents
12
Period of Report
2025-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20250610x8k.htm   iXBRL 8-K 42849
  Complete submission text file 0001558370-25-008512.txt   159030

Data Files

Seq Description Document Type Size
2 EX-101.SCH xlo-20250610.xsd EX-101.SCH 3401
3 EX-101.LAB xlo-20250610_lab.xml EX-101.LAB 16577
4 EX-101.PRE xlo-20250610_pre.xml EX-101.PRE 10707
14 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20250610x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 251037636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)